Edward Hutchins Bailey, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-453-5716 |
Savannah Willson Smith, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-5555 |
Ms. Chelsea Walker Tagawa, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-2202 Fax: 808-433-1153 |
Dr. Nathan Mcgraw, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-6345 |
Kyle Samblanet, Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-3313 |
Dr. Melanie A Medroso, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-6661 Fax: 808-433-1551 |
Phyllis Hoeflich Barr, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-6661 Fax: 808-433-1551 |
News Archive
The New York Times reports that the Obama administration has begun an effort to use these arguments as an opportunity to educate the public and build support for the overhaul. Meanwhile, the Los Angeles Times reports that one of the lead plaintiffs in a challenge to the law has gone bankrupt with outstanding medical bills, leading some to question whether this transforms her from a "symbol of proud independence into an example of exactly the problem the healthcare law was intended to address."
A new analysis has found that a combination of methods that help patients with dementia remember proper eating habits can improve their physical health and lessen symptoms of depression. Published early online in the Journal of Advanced Nursing, the study indicates that clinicians should consider using this intervention in individuals with dementia who also have poor nutrition and signs of depression.
Gilead Sciences, Inc. today announced that detailed results from four Phase 3 clinical trials (NEUTRINO, FISSION, POSITRON and FUSION) evaluating sofosbuvir, the company's investigational once-daily nucleotide NS5B inhibitor for the treatment of chronic hepatitis C virus infection, will be presented this week in oral sessions at the 48th Annual Meeting of the European Association for the Study of the Liver in Amsterdam, The Netherlands.
Savings estimates range from $1.5 billion to $4.6 billion — depending on the proposal. Policymakers are currently eyeing some of these options to reduce Medicare costs in the ongoing deficit-reduction talks.
› Verified 1 days ago